Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Total 1Q 2026 net product revenue of $191.2 million, representing 57% year-over-year growth AUVELITY® 1Q 2026 net product sales of $153.2 million, representing 59% year-over-year growth ...
Le Lézard
Services PMI® at 53.6%; April 2026 ISM® Services PMI® Report
Economic activity in the services sector continued to expand in April, say the nation's purchasing and supply executives in the latest ISM® Services PMI® Report. The Services PMI® registered 53.6 ...